Chemplast Sanmar Limited has informed the Exchange regarding - Constitution of Committee of Independent Directors

Revenue declinedNet loss reportedExceptional itemResults View source PDF Explain this filing

CHEMPLASTS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.8%Reaction day

₹246.00

prior close

₹252.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-6.5% vs market

Specialty Chemicals peers, median of 91sector-0.4%-5.4% vs sector

On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250 and 5.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.2

15m

-0.4

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.8+0.7-6.5-0.4-5.4

Next day

-9.6+0.7-10.3-0.3-9.3

-12.0+0.0-12.0-1.2-10.8

-10.8-1.1-9.8-2.3-8.6

-12.3+0.0-12.3-1.5-10.8

-15.8+0.3-16.0-2.2-13.6

-15.8+1.1-16.9-2.1-13.7

15d

-7.5+4.9-12.4+0.0-7.6

-18.7+5.3-24.0+0.0-18.7

-16.1+6.9-22.9+3.2-19.3

-27.7+11.9-39.6+4.5-32.2

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 91Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Chemplast Sanmar reported FY2026 standalone revenue of ₹2,170 crore, down 9.1% from ₹2,388 crore in FY2025. The company recorded a standalone net loss of ₹1,003 crore primarily due to an exceptional impairment charge of ₹898 crore related to its wholly-owned subsidiary Chemplast Cuddalore Vinyls (CCVL), which faces challenges from dropped anti-dumping duties on S-PVC, reduced customs duties on imports, and raw material price volatility. The Board did not recommend any dividend for FY2025-26. Mr V S Radhakrishnan was appointed as Non-Executive Non-Independent Director replacing Mr Sumit Maheshwari. The Board also constituted a Committee of three Independent Directors to evaluate strategic priorities including potential reorganization and M&A opportunities. Auditors issued unmodified opinions on both standalone and consolidated results.

Likely market impact

The ₹898 crore impairment is a significant one-time charge that masks underlying operational performance. The constitution of an Independent Directors committee to explore M&A opportunities signals potential strategic changes ahead. The revenue decline of ~9% and no dividend are negatives for shareholders, though the clean audit opinion provides some comfort.